Last Updated: June 24, 2026

Suppliers and packagers for acetadote


✉ Email this page to a colleague

« Back to Dashboard


acetadote

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539 NDA AUTHORIZED GENERIC Padagis US LLC 0574-0805-30 4 VIAL in 1 CARTON (0574-0805-30) / 30 mL in 1 VIAL 2012-12-20
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539 NDA Cumberland Pharmaceuticals Inc. 66220-207-30 4 VIAL in 1 CARTON (66220-207-30) / 30 mL in 1 VIAL 2004-01-23
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for acetadote

Last updated: June 2, 2026

ACETADOTE suppliers: who manufactures and supplies the acetylcysteine (Dosing) product for FDA distribution?

Who are the ACETADOTE suppliers and manufacturers?

ACETADOTE is a brand of acetylcysteine used for treatment of acetaminophen (paracetamol) overdose. Supply chain typically involves: (1) active pharmaceutical ingredient (API) manufacturers for acetylcysteine, (2) contract manufacturing organizations (CMOs) for sterile or liquid fill-finish (depending on the marketed dosage form), and (3) the FDA label holder and distributor of record for the finished drug.

No supplier list can be produced from the information provided.

What companies supply acetylcysteine used in ACETADOTE (API, intermediates, or finished product)?

Answer depends on:

  • the exact NDC and dosage form for ACETADOTE in the relevant market (e.g., premix/ready-to-use vs. reconstitutable formats),
  • whether the inquiry is for API only or finished sterile liquid,
  • and whether the “supplier” is interpreted as label holder, CMO, API site, or wholesaler/distributor.

No supplier data is available to enumerate companies, sites, or roles.

What does the FDA label list for ACETADOTE suppliers (label holder, manufacturer, and distributor of record)?

FDA labels for prescription products typically identify:

  • the labeler and manufacturer (site address),
  • sometimes the packer and distributor,
  • and in certain cases the firm responsible for specific manufacturing steps.

No ACETADOTE label/NDC-specific manufacturer or labeler identifiers were supplied, so suppliers cannot be listed.

Which wholesalers distribute ACETADOTE (U.S. distribution network)?

Wholesaler participation depends on:

  • the NDC(s) covered,
  • contract coverage and chargeback terms, and
  • regional distribution agreements.

No U.S. distributor list can be generated without the relevant NDC-level product mapping.

How to map ACETADOTE suppliers for procurement and compliance (NDC to sites)?

A procurement-grade mapping normally requires:

  1. the exact NDC (each pack size and presentation often differs),
  2. the FDA label’s manufacturer/distributor of record names and addresses,
  3. inspection history and site qualifications for those manufacturing sites,
  4. and internal sourcing classification (API vs. finished dosage form).

No ACETADOTE NDC or label text is provided, so a mapping cannot be built.

Key Takeaways

  • ACETADOTE is acetylcysteine for acetaminophen overdose, but supplier identification requires NDC/label-specific data.
  • No supplier companies (API, CMO, label holder, distributor of record, or wholesalers) can be listed from the current input.

FAQs

  1. What is the active ingredient in ACETADOTE?
  2. Is ACETADOTE an injectable or infusion product?
  3. How do I identify the manufacturer of record for ACETADOTE on the FDA label?
  4. Are ACETADOTE supply sources different by NDC?
  5. Who typically manufactures acetylcysteine API used for overdose treatments in the U.S.?

References

  1. (No sources cited; supplier data not provided.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.